Delivery Order SPE2DB22D7058-SPE2DB25FSWA4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,543.25 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 21, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Mestinon 60 mg tablets (100-count units) under a firm fixed-price arrangement with a ceiling value of $6,998.47 and an ultimate completion date of November 10, 2025. This non-set-aside award represents a small-value transaction within AmerisourceBergen's extensive federal pharmaceutical supply portfolio. The place of performance is listed in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Mestinon 60 mg, with performance in Conshohocken, Pennsylvania and a completion date of January 15, 2026. This non-set-aside contract was competitively awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a $25,032.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. The order was competitively awarded with no set-aside designation and is scheduled for completion by December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,037.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 14, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $2,569.50 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Mestinon 180 mg Timespan in units of 30, with completion scheduled for September 24, 2025. This firm fixed-price contract represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,667.30 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, for the supply of Mestinon 180 mg Timespan in units of 30 tablets. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025....
- The Defense Logistics Agency awarded a $9,466.34 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $3,382.75 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10.87K delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan tablets (30-count units) under a firm fixed-price contract structure. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB22D7058Indefinite Delivery Contract
- SPE2DB22D7058-SPE2DB25FSWA4Delivery Order
The Defense Logistics Agency awarded a $3,104.96 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Mestinon 60 mg tablets (100-count units). This is a firm fixed price contract with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for the Defense Logistics Agency's Medical Supply Chain and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This award for Mestinon, a medication used to treat myasthenia gravis, reflects the company's ongoing role in supporting Defense Health Agency procurement needs through competitive, firm fixed price delivery orders under its prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/2/25 |